AC Immune SA
ACIU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651625
No open-market purchases or sales by AC Immune SA insiders were filed in the last 90 days; 43 institutions reported holding it in 13F filings for Q2 2026, worth $58.2M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding AC Immune SA changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 42 | 47 | +5 |
| Shares | 25.9M | 25.2M | −695.2K (−2.7%) |
| Value | $81.2M | $69.2M | −$12.0M (−14.8%) |
New holders (9)
Institutions that held AC Immune SA at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 17,276 | $47.0K | 0.00% |
| XTX Topco Ltd | 14,304 | $39.3K | 0.00% |
| Gsa Capital Partners LLP | 11,530 | $32.0K | 0.00% |
| Jump Financial, LLC | 11,125 | $30.6K | 0.00% |
| Simplex Trading, LLC | 6,620 | $18.2K | 0.00% |
| Forum Finance Group S.A. | 2,000 | $5.00K | 0.00% |
| The PNC Financial Services Group, Inc. | 1,000 | $2.75K | 0.00% |
| Farther Finance Advisors, LLC | 43 | $120 | 0.00% |
| Caitong International Asset Management Co., Ltd | 3 | $8 | 0.00% |
Sold out (4)
Institutions that held AC Immune SA at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Point72 Asset Management, L.P. | 384,845 | $1.21M |
| SEI Investments Co | 15,884 | $49.9K |
| Leonteq Securities AG | 3,000 | $9.42K |
| SBI Securities Co., Ltd. | 547 | $1.72K |